Literature DB >> 12867636

Comparative analysis of the genome organization of human adenovirus 11, a member of the human adenovirus species B, and the commonly used human adenovirus 5 vector, a member of species C.

Ya-Fang Mei1, Johan Skog1, Kristina Lindman1, Göran Wadell1.   

Abstract

Adenovirus type 11 (Ad11), a member of the human adenovirus species B (HAdV-B), has a tropism for the urinary tract. The genome of Ad11 was found to comprise 34 794 bp and is 1141 bp shorter than the Ad5 genome of species HAdV-C. The G+C content of the Ad11 genome is 48.9 %, whereas that of Ad5 is 55.2 %. Ad11 and Ad5 share 57 % nucleotide identity and possess the same four early regions, but the E3 region of Ad11 could not be divided into E3A and E3B. The late genes of Ad11 and Ad5 are organized into six and five regions, respectively. Thirty-eight putative ORFs were identified in the Ad11 genome. The ORFs in the late regions, the E2B region and IVa2 show high amino acid identity between Ad11 and Ad5, whereas the ORFs in E1, E2A, E3 and E4, protein IX and the fibre protein show low amino acid identity. The highest and lowest identities were noted in the pre-terminal protein and fibre proteins: 85 % and 24.6 %, respectively. The E3 20.3K and 20.6K ORFs and the L6 agnoprotein were present in the Ad11 genome only, whereas the E3 11.6K cell death protein was identified only in Ad5. All ORFs but the E3 10.3K and L4 pVIII protein vary not only in composition but also in size. Ad11 may have a higher vector capacity than Ad5, since it has a shorter genome and a shorter fibre. Furthermore, in the E3 region, two additional ORFs can be deleted to give extra capacity for foreign DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867636     DOI: 10.1099/vir.0.19178-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.

Authors:  Lennart Holterman; Ronald Vogels; Remko van der Vlugt; Martijn Sieuwerts; Jos Grimbergen; Jorn Kaspers; Eric Geelen; Esmeralda van der Helm; Angelique Lemckert; Gert Gillissen; Sandra Verhaagh; Jerome Custers; David Zuijdgeest; Ben Berkhout; Margreet Bakker; Paul Quax; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.

Authors:  Wentao Gao; Adam C Soloff; Xiuhua Lu; Angela Montecalvo; Doan C Nguyen; Yumi Matsuoka; Paul D Robbins; David E Swayne; Ruben O Donis; Jacqueline M Katz; Simon M Barratt-Boyes; Andrea Gambotto
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Characterization of a new species of adenovirus in falcons.

Authors:  Mark Schrenzel; J Lindsay Oaks; Dave Rotstein; Gabriel Maalouf; Eric Snook; Cal Sandfort; Bruce Rideout
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11.

Authors:  Zhen Zhu; Yong Zhang; Songtao Xu; Pengbo Yu; Xiaoping Tian; Li Wang; Zhonghua Liu; Liuying Tang; Naiying Mao; Yixin Ji; Chongshan Li; Zhaohui Yang; Shiwen Wang; Jingjun Wang; Dexin Li; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

5.  Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.

Authors:  Han Hsi Wong; Guozhong Jiang; Rathi Gangeswaran; Pengju Wang; Jiwei Wang; Ming Yuan; Hexiao Wang; Vipul Bhakta; Heike Müller; Nicholas R Lemoine; Yaohe Wang
Journal:  Mol Ther       Date:  2011-11-15       Impact factor: 11.454

6.  Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery.

Authors:  Jason Seto; Michael P Walsh; Padmanabhan Mahadevan; Qiwei Zhang; Donald Seto
Journal:  Viruses       Date:  2010-01-06       Impact factor: 5.818

7.  The revolution in viral genomics as exemplified by the bioinformatic analysis of human adenoviruses.

Authors:  Sarah Torres; James Chodosh; Donald Seto; Morris S Jones
Journal:  Viruses       Date:  2010-06-28       Impact factor: 5.818

8.  Yeast Surface-Displayed H5N1 Avian Influenza Vaccines.

Authors:  Han Lei; Sha Jin; Erik Karlsson; Stacey Schultz-Cherry; Kaiming Ye
Journal:  J Immunol Res       Date:  2016-12-19       Impact factor: 4.818

Review 9.  [Research progress on early identification of severe adenovirus pneumonia in children].

Authors:  Jing Lin; Zhimin Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-07-25

10.  Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.

Authors:  Irene Kuhn; Paul Harden; Maxine Bauzon; Cecile Chartier; Julie Nye; Steve Thorne; Tony Reid; Shaoheng Ni; Andre Lieber; Kerry Fisher; Len Seymour; Gabor M Rubanyi; Richard N Harkins; Terry W Hermiston
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.